Revolution Medicines, Inc. (RVMDW) Net income 2018–2025
Revolution Medicines, Inc. (RVMDW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.1BFY2025 · since FY2018: -$41.8M → -$1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.1B | -88.5% |
| FY2024 | -$600.0M | -37.6% |
| FY2023 | -$436.0M | -75.1% |
| FY2022 | -$249.0M | -33.2% |
| FY2021 | -$187.0M | -72.9% |
| FY2020 | -$108.2M | -126.9% |
| FY2019 | -$47.7M | -14.1% |
| FY2018 | -$41.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice